Aneurysm Clinical Trial
Official title:
Totally Percutaneous Approach to Endovascular Treatment of Aortic Aneurysms (PEVAR-PRO)
Purpose of the study is the evaluation of the applicability of the percutaneous technique through double Proglide and Pre-Close Technique to the treatment of complex aortic aneurysms with thoracic endoprosthesis (TEVAR), fenestrated or branched (F / B-EVAR) in which patient-related factors, the devices used or the procedure, could affect the performance.
Endovascular treatment using a percutaneous technique (Percutaneous Endovascular Aneurism
Repair - P-EVAR) has been used with increasing frequency to treat aortic aneurysms by
reducing operative times, postoperative pain and length of stay, compared to treatment by
surgical femoral access. During EVAR procedures, two accesses to the femoral arteries are
required to introduce the necessary tools for the stentgraft implantation. Such accesses can
be classically obtained by surgical incision, isolation of the common femoral arteries and
direct introduction of the devices.
Alternatively, the most modern approach involves direct puncture of the artery (without the
need for incision), through the skin and closure of the arterial breach through prolonged
manual compression of the vascular closure or systems (Vascular Closure Devices - VCD)
specifically designed. Among the various closure devices one of the most used and studied is
the Perclose Proglide (Abbott Vascular, Santa Clara CA, USA) that allows to affix a
polypropylene stitch to close the arterial breach. When closing high-caliber accesses (> 8
French) it is necessary to use two devices that must be positioned before inserting the
introducer ("Pre-Close Technique").
Few studies have so far evaluated the application of this method to the treatment of complex
cases such as thoracic or thoracoabdominal aortic aneurysms that requiring the use of high
caliber introducers.
The objective of the study is the evaluation of the technical success and clinical outcomes
of the PEVAR technique with a double vascular suture device Perclose ProGlide (Abbott
Illinois, U.S.A.).Endovascular treatment using a percutaneous technique (Percutaneous
Endovascular Aneurism Repair - P-EVAR) has been used with increasing frequency to treat
aortic aneurysms by reducing operative times, postoperative pain and length of stay, compared
to treatment by surgical femoral access. During EVAR procedures, two accesses to the femoral
arteries are required to introduce the necessary tools for the stentgraft implantation. Such
accesses can be classically obtained by surgical incision, isolation of the common femoral
arteries and direct introduction of the devices.
Alternatively, the most modern approach involves direct puncture of the artery (without the
need for incision), through the skin and closure of the arterial breach through prolonged
manual compression of the vascular closure or systems (Vascular Closure Devices - VCD)
specifically designed. Among the various closure devices one of the most used and studied is
the Perclose Proglide (Abbott Vascular, Santa Clara CA, USA) that allows to affix a
polypropylene stitch to close the arterial breach. When closing high-caliber accesses (> 8
French) it is necessary to use two devices that must be positioned before inserting the
introducer ("Pre-Close Technique").
Few studies have so far evaluated the application of this method to the treatment of complex
cases such as thoracic or thoracoabdominal aortic aneurysms that requiring the use of high
caliber introducers.
The objective of the study is the evaluation of the technical success and clinical outcomes
of the PEVAR technique with a double vascular suture device Perclose ProGlide (Abbott
Illinois, U.S.A.).
This is a retrospective observational study (320 cases treated in San Raffaele hospital in
Milan, during the period: October 2015 - 31 December 2019).
The chronology of the assessments will include:
- An immediate evaluation at the end of the procedure by performing the ecocolordoppler
examination of the percutaneous accesses performed (as per routine). On the basis of
longitudinal and sagittal scans of the vessel, the Physician must check the presence of
the above complications that could be considered as "failure" of percutaneous access. In
the event that these complications are clinically evident (eg uncontrollable bleeding
from the puncture site), in the interest of a prompt management of the surgical problem,
it will not be necessary to perform an ecocolordoppler examination and the outcome will
be assigned "failure ".
- A second echocolordoppler assessment performed on the first postoperative day (as per
routine) The study will be conducted in accordance with the ethical principles deriving
from the Helsinki Declaration and the current legislation on Observational Studies.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06235619 -
Arch Size Study for Anatomical Variations
|
||
Not yet recruiting |
NCT00905931 -
Lycopene Following Aneurysmal Subarachnoid Haemorrhage
|
Phase 2 | |
Completed |
NCT01178710 -
Effect of Simvastatin on Cardiac Function
|
N/A | |
Completed |
NCT00349908 -
A Feasibility Study of the Cordis Neurovascular Self Expanding Stent System in Intracranial Arteries
|
Phase 1 | |
Recruiting |
NCT03285100 -
The Effects of Discontinuation of Vitamin K Antagonists on the Rate of Elastin Degradation
|
N/A | |
Recruiting |
NCT06189950 -
Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms:REBRIDGE
|
N/A | |
Active, not recruiting |
NCT04592185 -
The Study of the Fenestrated Anaconda Device in the Treatment of Abdominal Aortic Aneurysms
|
||
Completed |
NCT01970605 -
Silver Graft All Comers Registry
|
||
Completed |
NCT00282893 -
Balloon Prophylaxis of Aneurysmal Vasospasm
|
Phase 2 | |
Active, not recruiting |
NCT00549380 -
Clinical Study of Aneurysm Exclusion
|
Phase 1 | |
Completed |
NCT04598802 -
COvera in BRAnch Registry
|
||
Completed |
NCT04246125 -
Patient Skin Dose in Interventional Radiology
|
||
Recruiting |
NCT05829746 -
PROSPECTIVE, MULTI-CENTER, OPEN-LABEL, SINGLE-ARM REGISTRATION TRIAL OF THE TUBRIDGE FOR THE TREATMENT OF WIDE-NECKED SMALL AND MEDIUM-SIZED INTRACRANIAL ANEURYSMS
|
N/A | |
Completed |
NCT03242343 -
VasQ External Support for Arteriovenous Fistula
|
N/A | |
Recruiting |
NCT02878967 -
Standardized Long Term Follow-up of Patients After Endovascular Embolization of a Brain Aneurysm
|
||
Active, not recruiting |
NCT02345005 -
Iliac Branch Excluder ReGistry (IceBERG)
|
||
Recruiting |
NCT02167997 -
EffectiveNess and SAfety of Small ANeurysm COiling Trial
|
N/A | |
Recruiting |
NCT00549016 -
Clinical Study of Aneurysm Exclusion
|
N/A | |
Completed |
NCT02848612 -
Evaluation of the Amiens University Hospital Neuroradiology Anticoagulation Protocol
|
||
Enrolling by invitation |
NCT04269447 -
Prospective Aortic Biobank of POP-STAR
|